Showing results (1061-1070 of 1,099) with videos related to

Sort By:
Pageof 110
Theranostics|February 23, 2024
Global metabolomics revealed deviations from the metabolic aging clock in colorectal cancer patientsLong Zhang, Shaobo Mo, Xiurui Zhu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 21, 2025
Metabolic pathway alterations in cerebrospinal fluid as diagnostic biomarkers for primary central nervous system lymphomaJingjing Ma, Di Wang, Xiangyu Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 3, 2018
Human ISL1<sup>+</sup> Ventricular Progenitors Self-Assemble into an In Vivo Functional Heart Patch and Preserve Cardiac Function Post InfarctionKylie S Foo, Miia L Lehtinen, Chuen Yan Leung, et al.
Frontiers in Immunology|October 20, 2022
Single center blind testing of a US multi-center validated diagnostic algorithm for Kawasaki disease in TaiwanHo-Chang Kuo, Shiying Hao, Bo Jin, et al.
Frontiers in Immunology|August 15, 2024
Targeted multiplex validation of CSF proteomic biomarkers: implications for differentiation of PCNSL from tumor-free controls and other brain tumorsJingjing Ma, Zhiguang Lin, Yaqi Zhang, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjectsRajesh Krishna, Amit Garg, Deborah Panebianco, et al.
The Lancet. Respiratory Medicine|September 13, 2024
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory studyYongfeng Yu, Qisen Guo, Yongchang Zhang, et al.
The Lancet Regional Health. Western Pacific|April 6, 2026
Efficacy and safety of savolitinib in Chinese patients with locally advanced or metastatic <i>MET</i> exon 14-mutated non-small cell lung cancer: final results of a confirmatory Phase 3b studyYongfeng Yu, Qisen Guo, Yongchang Zhang, et al.
Metabolites|June 27, 2023
Development of a Urine Metabolomics Biomarker-Based Prediction Model for Preeclampsia during Early PregnancyYaqi Zhang, Karl G Sylvester, Bo Jin, et al.
BMC Cancer|September 2, 2024
Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II studyYu Cheng, Zan Teng, Yanqiao Zhang, et al.
Pageof 110